BrainMap

Mr. Bruno Stefan Velescu

PhD

Associate Professor - UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"

Researcher | Teaching staff | Scientific reviewer

Web of Science ResearcherID: 55390200100

Curriculum Vitae (13/10/2019)

Expertise & keywords

Development of anticancer nanoparticulate systems based on novel metal complexes Call name: P 2 - SP 2.1 - Proiect experimental - demonstrativ
PN-III-P2-2.1-PED-2019-5143 2020 - 2022

Role in this project:

Coordinating institution: INSTITUTUL DE VIRUSOLOGIE "STEFAN S.NICOLAU"

Project partners: INSTITUTUL DE VIRUSOLOGIE "STEFAN S.NICOLAU" (RO); UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" (RO)

Affiliation: UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" (RO)

Project website: https://www.virology.ro/ro/cercetare/proiecte/proiect-ped-383-2020

Abstract:

A new generation of efficient metal-based drugs needs to be developed in order to overcome the biological, biopharmaceutical and biomedical drawbacks of standard chemotherapy. Use of metallo-drugs in cancer treatment has been hampered by an indaquate pharmacokinetic profile that limited the access to the biological target. This has led to the development of novel technologies based on nanostructured materials, acting as vectors for metallodrug delivery or simply as protectors of active species of the complexes for amplifying their activities and reducing their degradation. The aim of the project is to develop and validate new liposomal systems for transport and delivery of 2 promising anticancer agents previously studied by our research group. Nanoparticulate drug carrier systems will improve the therapeutic effectiveness and safety profile of these novel anticancer agents. The efficiency of these nanoformulations will be evaluated in terms of stability, drug entrapment efficiency, release behaviour, cell uptake, cytotoxicity, farmacotoxicology and pharmacokinetics. The project specific objectives are: 1) Development of liposomal systems validated at the laboratory level with novel anticancer agents; 2) Estimation the in vitro biological activity of the liposomal systems on various cell lines, including drug resistant cell lines, identifying biomarkers involved in modulating their biological activity; 3) Estimating the pharmaco-toxicological and pharmacokinetic profile of liposomal systems. Nanoparticles provide an enhanced bioavailability, in vivo stability, intestinal permeability, solubility, sustained and targeted delivery, therapeutic effectiveness of the anticancer drugs. The proposed project is a complex, interdisciplinary study related to biomedical international research, that aims to intends to transform modern methods, worldwide used in pharmacological, immunological and molecular biology studies, in instruments used for the translation to oncology.

Self-emulsifying delivery system for new metal complexes as materials with potential health use Call name:
15BM/2016 2016 - 2017

Role in this project: Project coordinator

Coordinating institution: UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"

Project partners: UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" (RO)

Affiliation: UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" (RO)

Project website:

Abstract:

Sortase A inhibitors. New therapeutic approach for the management of infections with gram-positive multiresistant cocci Call name: Projects for Young Research Teams - RUTE -2014 call
PN-II-RU-TE-2014-4-1670 2015 - 2017

Role in this project:

Coordinating institution: UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA

Project partners: UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO)

Affiliation: UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO)

Project website: https://umfcd.ro/cercetare-si-dezvoltare/proiecte/proiecte-de-cercetare/sortase-a-inhibitors-new-therapeutic-approach-for-the-management-of-infections-with-gram-possitive-multiresistant-cocci/

Abstract:

The project tries to resolve the problem of the limited number of therapeutic resources for the management of gram-positive multiresistant cocci infections. Based on the project leader's expertise in targeted-drug design and in antimicrobial agents’ development, the project has the objectives to synthesize original molecules designed to target sortase A, to validate their effectiveness as anti-enterococcal agents, to assess their safety profile and to extend the research on other pathogens within the group of positive cocci. The compounds will be subjected to physicochemical and biopharmaceutical analyses, will be tested on susceptible/resistant bacterial strains. Toxicity assessment will use alternative methods including the use of Jurkat cell cultures and invertebrate models, like Artemia salina and Daphnia magna, with the purpose of reducing the number of animals used further. Structure-activity relationship analysis will be used for structural optimization. The results of the present project can be used to obtain original Romanian drugs with antimicrobial activity and to decrease the morbidity and mortality of affected patients. A special emphasis was put in promoting young, but experienced, researchers in a well-balanced interdisciplinary team.

Studies on soil-plant-food-man correlations to obtain a food supplement with an increased content in iron of herbal origin Call name: Joint Applied Research Projects - PCCA 2013 - call
PN-II-PT-PCCA-2013-4-1572 2014 - 2017

Role in this project:

Coordinating institution: UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA

Project partners: UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO); HOFIGAL EXPORT IMPORT SA (RO); AGROECO BIOTERRA SRL (RO)

Affiliation: UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO)

Project website: http://saliferoveg.umf.ro/index.html

Abstract:

Iron deficiency anemia (IDA) is the most common form of anemia in the world and the most frequent form of anemia in pregnant women. It is estimated that IDA has a prevalence of 2% among adult men and 9–20% among adult women. The multiple negative effects of anemia on health and quality of life justify the interventions designed to prevent and control anemia and the most important such intervention is the use of iron-containing food supplements.

The core objective of this project is to develop an iron-containing food supplement, using iron in its natural form, as an extract from plants rich in this oligoelement and, for this purpose, at exploring the correlations between soil, plants and the developed food supplement, to ensure an optimal use in humans. There are very few food supplements of botanical origin containing iron on the Romanian market (most of those available use iron salts). There is only a food supplement of Chinese origin containing iron (10 mg/tablet) and folic acid, the iron being derived from an extract of the so-called “black fungi powder” (with no taxonomic identification of the fungi species) and one manufactured locally (in two slightly different formulas) but with very small amounts of iron (“Fier biologic”, containing much less than 1.0 mg of Fe per capsule).

For this purpose we would explore the correlation between soil iron and iron in plants, by analyzing iron contents in at least 10 plant species (for at least 2 parts of the plant species – root, stem, leaf, seeds) grown on various soils in Romania and using statistical methods of regression to verify the relationship between the two variables. Because – as shown in section 1.2. – iron bioavailability is most often affected by other components of the plants (especially phytates, polyphenols and flavonoids), we will also investigate the influence of the soils on the flavonoids and polyphenol contents (as phytates is most often found in significant amounts only in seeds and grains we will not investigate phytate).

Very little research has been concerned up to now to the correlation between plant iron uptake and polyphenols or flavonoid content in various plant parts. We will also explore the relationship between the ontogenetic stages of plants and their iron uptake. The studies published up to date have only looked into this relationship in a small number of species and have produced inconsistent results. These results will allow us to make a scientifically sound decision on what parts of the plants to use, at what maturity stage to be collected and grown on what soils, as starting material for an extract rich in iron. We will also investigate the best iron extraction method from herbal sources and the main variables affecting the efficiency of the extraction process of iron in its natural form from plants (the following variables will be investigated: extraction method, solvent, temperature, herbal product:solvent ratio, extraction time and particle size) and the possibility of obtaining and characterizing a standardized extract (to be used as a raw material for a finished product). Finally, we will formulate and develop an iron-containing food supplement of herbal origin at the prototype stage.

The project will create research synergies through the collaboration of three partners: the University of Medicine and Pharmacy “Carol Davila” Bucharest (with a multidisciplinary team comprising experts in pharmaceutical botany, phytochemistry, analytical chemistry, physical chemistry, pharmaceutical chemistry, pharmacology, pharmaceutical technology) SC Hofigal Export Import, one of the most important manufacturers of food supplements of herbal origin on the Romanian market and SC Agroeco Bioterra SRL, a company specialized in ecologically cultivating medicinal herbal species, being independently certified in this sense.

INNOVATIVE THERAPEUTIC PRODUCTS WITH PROPHILACTIC AND CURATIVE ACTION FOR ZOO-VETERINARY SECTOR Call name: Joint Applied Research Projects - PCCA 2013 - call
PN-II-PT-PCCA-2013-4-0953 2014 - 2017

Role in this project:

Coordinating institution: UNIVERSITATEA DE STIINTE AGRONOMICE SI MEDICINA VETERINARA

Project partners: UNIVERSITATEA DE STIINTE AGRONOMICE SI MEDICINA VETERINARA (RO); UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO); ASOCIATIA CENTRU DE CERCETARE STIINTIFICA IN DOMENIUL BIOCHIMIEI APLICATE SI BIOTEHNOLOGIEI (BIOTEHNOL) (RO); BIOING S.A. (RO); HOFIGAL EXPORT IMPORT SA (RO)

Affiliation: UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO)

Project website: http://sanovet.fifim.ro/

Abstract:

Title: „INNOVATIVE THERAPEUTIC PRODUCTS WITH PROPHILACTIC AND CURATIVE ACTION FOR ZOO-VETERINARY SECTOR”

Acronym: SANOVET

Program: PARTNERSHIPS

Subprogram: “ Applied Collaborative Research Projects”

Domain 5 - Agriculture, food safety and security

Research thematic: 5.1.4. Methods, techniques and technologies for growth and diversification of animal production and fisheries, veterinary protection insurance Animal health is a concern for all European citizens. This concern stems from the public health, food safety and food security aspects, which are related to animal health but also to economic costs that animal disease outbreaks can trigger. This project uses a very common and a high economical and ecologically impact disease model like inflammation, as a paradigm for a conceptual and practical approach aimed to capitalize inexpensive and available resources.

The project goal is to improve the level of veterinary protection by developing a semi - solid phytoproduct from indigenous flora with topical application.

Main objectives that will ensure the achievement of project aim are:

1. Obtaining crops to exploit the curative potential of Anthriscus sp.;

2. Obtaining the phytocomplex;

3. Evaluating extracts pharmacological viability;

4. Obtaining an innovative phytoproduct .

The results of this research project will be materialized through:

1. Development and characterization of a herbal extract enriched in active ingredients with a complex chemical structure, non-toxic, based on original recipe obtained from association of fractionated extract with volatile oil from Anethum sp properly processed,

2. Highlighting the biologic activity, which plays a role in sustaining and accelerating the healing process by in vivo testing of herbal extract,

3. Creating a new topic semisolid phytoproduct.

The project addresses to a major agricultural problem in an interdisciplinary aggregate approach in order to achieve high yields results with a low economical input and a great environmental safety.

RESEARCH AND FORMULATION OF A NEW CLASS OF SYNERGIC ANALGESIC - ANTIINFLAMMATORY DRUG COMBINATIONS WITH IMPROVED BIOAVAILABILTY, EFFICACY AND SAFETY PROFILE Call name: Joint Applied Research Projects - PCCA 2013 - call
PN-II-PT-PCCA-2013-4-2071 2014 - 2017

Role in this project:

Coordinating institution: UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA

Project partners: UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO); Spitalul Universitar de Urgenta Militar Central "Dr.Carol Davila" (RO); UNIVERSITATEA DE MEDICINA SI FARMACIE CRAIOVA (RO); UNIVERSITATEA BUCURESTI (RO); POLIPHARMA INDUSTRIES S.R.L. (RO)

Affiliation: UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO)

Project website: http://www.algosyn.org

Abstract:

The project aims a “faster medicine” (an European priority), an unitary, optimal, complete approach, from pharmacological design to clinical trial and industrial development of synergic combinations of an analgesic (acetaminophen), an analgesic - anti-inflammatory (acetylsalicylic acid), caffeine and chlorphenamine or other antihistaminic, exhibiting analgesic, anti-inflammatory and decongestive action, formulated as tablets, enterosoluble dragees, capsules.

The technical problem proposed to be solved in the project is that of obtaining the anti-inflammatory, analgesic and decongestant effects in pain related to inflammatory processes, particularly those in migraine, lumbar discopathy and/or lumbago, when smaller than regular quantities of active substances are administered, with relative higher efficiency than the substances administered individually and with reduced side effects and higher patient tolerance.

Additional to superior effects in comparison with the individual components, the essential , original feature of the new products will be that of obtaining comparable effects as other similar drug combinations but at two-three times lower doses, which implies also a significant reduction of adverse events. Particularly, the administration of acetylsalicylic acid as a nanostructured formulation diminishes high local concentrations of dissolved drug in the gastro-intestinal tract which is expected to minimize gastro-intestinal irritancy.

Research looks for a class of new combinations having as leading drug a synergic combination between chlorphenamine, caffeine, acetaminophen and acetylsalycilic acid, existing in the weight ratios of 1/10/30/40) patented by the project director and finalized as a drug, Algopirin, authorized by National Medicines Agency and produced by the industrial partner of the project. The most remarkable result was a strong anti-migraine effect.

The originality of the project lies also in the methodology and phenomenological modelling. The methodological approach will be based on powerful design of experiments, mainly cross-over, mathematical modelling and statistical tools. This could offer a chance of understanding the variability mechanisms and time-course of the processes which will allow to obtain statistical and clinical significant results, starting from a minimum number of experimental and clinical trials.

Pharmaco/ Toxico/ Kinetics and Dynamics modelling would have as result the elaboration of general and personalized therapeutic schedules for new drugs, prevention of non- responsiveness appearance following an inappropriate pharmacokinetics. Design, elaboration and characterization of classical and/or supramolecular organic core-shell nano-silica reservoirs, for release of active components, will be the contribution in the project of the colloid chemistry partner team and the industrial partner of the project. Nanostructured formulations will provide improved dissolution rate of active components that would result in enhanced bioavailability allowing a smaller dose to achieve same in vivo blood levels.

The most significant feature of the project is the aim of finalizing the researches with new, in the same time more safe and efficient drugs.

Obtaining new vector types for their phytotherapeutical principles, by means of biotechnological processes and the modeling of the phytotherapeutical principle's release mechanism Call name: Joint Applied Research Projects - PCCA 2013 - call
PN-II-PT-PCCA-2013-4-0034 2014 - 2017

Role in this project:

Coordinating institution: INSTITUTUL NATIONAL DE CERCETARE DEZVOLTARE PENTRU STIINTE BIOLOGICE

Project partners: INSTITUTUL NATIONAL DE CERCETARE DEZVOLTARE PENTRU STIINTE BIOLOGICE (RO); INSTITUTUL DE CHIMIE FIZICA - ILIE MURGULESCU (RO); INSTITUTUL NATIONAL DE CERCETARE-DEZVOLTARE PENTRU TEXTILE SI PIELARIE-I.N.C.D.T.P. BUCURESTI SUCURSALA BUCURESTI INSTITUTUL DE CERCETARE PIELARIE - INCALTAMINTE I.C.P.I. (RO); UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO); CENTRUL DE CERCETARE SI PRELUCRARE A PLANTELOR MEDICINALE PLANTAVOREL SA (RO)

Affiliation: UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO)

Project website: http://www.incdsb.ro/p/NEWBIOVECT/index.htm

Abstract:

The goal of the NEWBIOVECT consortium is to develop a new biomimetic biovectors – complex of the multi-membranes and active principles of a phytocomplex obtained from Symphytum officinale, Betonica officinalis, Salvia officinalis and Impatiens L. species concentrated extracts, such as polyphenols (can mimic the effects of cytokines, they have also been involved in the regulation of cell division and expansion), flavones, saponins (anti-inflammatory compounds that mimic the action of steroids), allantoin and polysaccharides (stimulate proliferation of keratinocytes and dermal fibroblasts). The project also aims to release in vitro and in vivo a therapeutic dosage of drug that heals wounds and reduces the inflammatory effects. The new biovectors will be will be kinetically characterized and will be establish of the mechanisms involved in the kinetic processes.

The development of new, advanced systems biovector phytotherapeutic compounds (active ingredients) aim to the skin wounds’ treatment improvement as well as shorter the hospital recovery time. This project focuses also on the superior valorizing of some well-known medicinal herbs (Symphytum officinale and Salvia officinalis), as well as the higher valorizing of Impatiens L. Species and Betonica officinalis which has not yet been introduced in Romania, for research and proceeding by now. Additionally, this project aims to transfer the new knowledge in the economic environment for a more efficient use of medicinal and aromatic plant species, and increase the quality and competitiveness of Romanian’s phyto-pharmaceutic products on domestic and foreign market.

The project results will get a technological impact considering the development of some new, nonconventional processes with high efficiency, in Romania, for obtaining and processing the herbs extracts.

The main objectives of the NEWBIOVECT project are: i) design and synthesis of novel polymeric and composite multi-membrane systems, macroporous and nanoporous membranes for active principles of a phytocomplex obtained from Symphytum officinale, Betonica officinalis, Salvia officinalis and Impatiens L. species concentrated extracts delivery; ii) kinetic studies concerning the active principles in vitro release from the obtained supports, and testing the obtained support for their biocompatibility; iii) accomplishment of the biovectors’ experimental lots for the phytopharmaceutical products with reproducible characteristics and evaluate in vivo therapeutic efficacy.

Design and development of transport and delivery systems for new ruthenium compunds with antitumor activity Call name: Joint Applied Research Projects - PCCA-2011 call, Type 2
PN-II-PT-PCCA-2011-3.2-1454 2012 - 2016

Role in this project:

Coordinating institution: UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA

Project partners: UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO); INSTITUTUL ONCOLOGIC PROF.DR.ALEXANDRU TRESTIOREANU BUCURESTI (RO); UNIVERSITATEA BUCURESTI (RO); INSTITUTUL DE VIRUSOLOGIE "STEFAN S.NICOLAU" (RO); PHARMA SERV INTERNATIONAL SRL (RO)

Affiliation: UNIV.DE MEDICINA SI FARMACIE - CAROL DAVILA (RO)

Project website: http://cercetare-umf.ro/uploads_ro/592/Pagina_web_136_2012-actualizata_2016.pdf

Abstract:

The proposed cooperative study is a complex interdisciplinary approach aimed at developing pharmaceutical product models with significant antitumor action and minimal side effects. During the project, three pharmaceutical systems that include some ruthenium complexes will be studied regarding solubility, capacity to transport and deliver the active substance at the final site of action, the antitumor activity and the side effects. The final scope of the project is to select the system (or systems) who best meet the requirements regarding bioavailability and pharmaco-toxicological properties for a possible inclusion in the clinical trials of the studied ruthenium complexes.

The proposed project has least three main goals. First, we want to develop pharmaceutical systems for improve the solubility of some ruthenium compounds in order to achieve a better pharmacokinetic profile for these compounds. Second, we intend to evaluate the antitumor activity of the developed systems using various cell lines from solid tumors and in vivo, comparing to cisplatin as reference substance. Third, we intend to evaluate the general toxicity of the developed systems, comparing to cisplatin. Additionally, we want to explore the possibility of development of these products as oral drugs and to establish what kind of cancer can be treated with these agents.

Synthesis and Antitumor Evaluation of Novel Pyrazole Compounds Call name: Projects for Young Research Teams - TE-2011 call
PN-II-RU-TE-2011-3-0228 2011 - 2014

Role in this project:

Coordinating institution: Universitatea de Medicina si Farmacie Carol Davila

Project partners: Universitatea de Medicina si Farmacie Carol Davila (RO)

Affiliation: Universitatea de Medicina si Farmacie Carol Davila (RO)

Project website: http://www.umfcaroldavila.ro/index.php/activitatea-stiintifica/programe-pnii/447-sinteza-si-evaluarea-antitumorala-a-unor-noi-compusi-pirazolici

Abstract:

The project focuses on improving the therapeutic solutions for a better treatment of the cancer patients by designing selective chemotherapeutic agents. The project main objective is the synthesis, the complex physical and chemical analysis followed by the anticancer screening, of a broad series of novel pyrazole based small-molecules for using them in antitumor therapy. In order to achieve this objective, we will use iterative cycles of design and chemical synthesis combined with biological evaluation, thereby progressively optimizing potency and selectivity while paying due attention to pharmaceutical and ADME (Absorption, Distribution, Metabolism, and Excretion) properties. Modern computerized prediction methods (in silico) will be performed to estimate the bio-pharmaceutical properties and the drug-likeness of the designed molecules, prior to their synthesis, greatly minimizing time and resources consuming steps of synthesis and biological screening of unfit molecules. State of the art equipment and methods will be used for the compounds synthesis and to determinate their physico-chemical and structural characteristics (HPLC-MS, IR, NMR, elemental analysis). The compounds anticancer quantitative evaluation will be performed in vitro on various human tumor cell lines, representing different cancer types, measuring also the substances effect on apoptosis and on the cell cycle. Structure-activity relationships studies will allow the optimization of the anticancer effects.

Susținerea mecanismelor instituționale de corelare a ofertei educaționale a UMFCD cu cerințele din piața muncii Call name: Fondul de Dezvoltare Instituţională - FDI - Competiţia 2024
CNFIS-FDI-2024-F-0584 2024 -

Role in this project:

Coordinating institution: UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"

Project partners: UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" (RO)

Affiliation:

Project website:

Abstract:

Optimizarea mecanismelor instituționale de corelare a ofertei educaționale cu cererea pieței muncii pentru o carieră de succes în domeniul Sănătate Call name: Fondul de Dezvoltare Instituţională - FDI - Competiţia 2023
CNFIS-FDI-2023-F-0720 2023 -

Role in this project:

Coordinating institution: UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"

Project partners: UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" (RO)

Affiliation:

Project website:

Abstract:

Pentru atingerea scopului proiectului se definesc următoarele obiective:

O1. Consolidarea parteneriatelor dintre UMFCD și mediul socio-economic. Prin acest obiectiv se urmărește demararea unor discuții, pe bază de acorduri de colaborare, cu angajatori din domeniul Sănătate cu interes în noile tendințe de dezvoltare tehnologică. În acest fel se urmărește identificarea unor competențe noi necesare creșterii competitivității pieței muncii.

O2. Orientarea studenților către cariera de cercetător. Prin acest obiectiv se urmărește creșterea atractivității carierei de cercetător în domeniul Sănătate, prin inițierea unui program de shadowing, care visează valorificarea abilităților dobândite de către studenți și orientarea acestora spre cercetare. Suplimentar în cadrul acestui obiectiv se va evalua parcursul profesional al studenților UMFCD, prin intermediul Centrul de Consiliere Psihologică, Educațională și Profesională, printr-o o analiză obiectivă asupra competențelor dobândite și cariera vizată.

O3. Corelarea competențelor absolvenților UMFCD din domeniul Sănătate cu cerințele mediului socio-economic. Prin acest obiectiv se urmărește consultarea actorilor principali din domeniul Sănătate cu privire la competențele resursei umane implicate în activități specifice domeniului precum și la activitățile de orientare in carieră în vederea creșterii competitivității.

O4. Actualizarea competențelor furnizate de UMFCD în funcție de nevoile identificate pe piața muncii, identificate la nivel instituțional. Prin acest obiectiv se urmărește ca la nivel instituțional să se consolideze infrastructura necesară formării de resursă umană înalt competentă în domeniul Sănătate.

Realizarea acestor obiective, la nivelul proiectului, urmărește creșterea adaptabilității instituționale la dinamica mediului socio-economic și va consolida misiunea UMFCD de a genera și transfera cunoaștere către societate în domeniul Sănătate contribuind în acest fel la formarea de resursă umană înalt calificată

Optimizarea mecanismelor instituționale de corelare a ofertei educaționale cu cererea pieței muncii Call name: Fondul de Dezvoltare Instituţională - FDI - Competiţia 2022
CNFIS-FDI-2022-0250 2022 -

Role in this project:

Coordinating institution: UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA"

Project partners: UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" (RO)

Affiliation:

Project website:

Abstract:

Pentru atingerea scopului proiectului, în corelație cu misiunea UMFCD de educație și de a genera și transfera cunoaștere către societate în domeniul Sănătate, la nivel instituțional se urmărește optimizarea și consolidarea procesului de corelare a ofertei educaționale cu cererea pieței muncii prin următoarele obiective:

O1.Identificarea principalelor cerințe din piața muncii legate de competențele angajaților din Sănătate. Acest obiectiv presupune consultarea actorilor din domeniul Sănătate: organizații profesionale, angajatori, angajați privind nevoile actuale din piață, pentru a forma specialiști cu competențe extinse adaptate acestora. În contextul inițiativei europene Sănătate digitală (https://digitalhealtheurope.eu), sectorul digital va fi abordat în cadrul consultărilor, ca cerință identificată la nivel Instituțional.

O2.Inițierea/consolidarea unor competențe furnizate de UMFCD necesare inserției în piața muncii. Acest obiectiv va corela curriculumul academic de pregătire al studenților UMFCD şi al absolvenților UMFCD sau altor instituții de profil, cu nevoile identificate în cadrul O1 pentru elaborarea unor programe de pregătire complementară care să asigure generarea competențelor cerute

O3.Inițierea/consolidarea unor parteneriate cu instituții cu expertiză complementară UMFCD. Acest obiectiv presupune optimizarea fluxului instituțional referitor la implicarea mediului socioeconomic în programe de formare de specialiști cu competențe sporite adaptate nevoilor actuale

FILE DESCRIPTION	DOCUMENT
List of research grants as project coordinator or partner team leader
Significant R&D projects for enterprises, as project manager
R&D activities in enterprises
Peer-review activity for international programs/projects